Should Azithromycin No Longer Be Considered a Drug of Choice for Community- Acquired Pneumonia Because of Its Potential to Cause Cardiovascular Death?

Heather Kertland (Pro), Michael B Kays (Con)

Abstract


-

Full Text:

PDF HTML


DOI: http://dx.doi.org/10.4212/cjhp.v66i5.1292

ISSN 1920-2903 (Online)
Copyright © 2019 Canadian Society of Hospital Pharmacists